Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer

Study Description

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

RATIONALE: Learning about the amount of information on fertility and infertility by patients before they received treatment for cancer in a comprehensive cancer center may help doctors plan the best treatment.

PURPOSE: This clinical trial is studying the amount of information on fertility and infertility received by patients before treatment of cancer in patients who have finished treatment.

Condition or disease	Intervention/treatment
Cancer	Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: assessment of therapy complications; Procedure: fertility assessment and management; Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment

Detailed Description:

OBJECTIVES:

Primary

• To determine the amount of information received on aspects of fertility and infertility in patients with cancer prior to receiving treatment in a comprehensive cancer center.

Secondary

• To analyze whether the information received by patients is related to the desire to be parents.
• To analyze whether the information received by patients is related to the desire to be informed.
• To determine whether there is a relationship between demographic data, diagnosis, quality of life, and associated psychosocial information received by patients.

OUTLINE: Patients complete questionnaires (Lickert and QLQ-C30) on the amount of information received prior to therapy and psychosocial issues on aspects of fertility and infertility once within 1-2 years after receiving treatment.

Study Design

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Observational
Estimated Enrollment :	96 participants
Official Title:	Descriptive Study to Evaluate the Information and Psychosocial Issues on the Risk on Infertility in Cancer Patients After Receiving Treatment in a Comprehensive Cancer Center
Study Start Date :	December 2010
Estimated Primary Completion Date :	June 2012

Groups and Cohorts

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Outcome Measures

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :

1. Amount of information received on aspects of fertility and infertility
2. Relationship between demographic data, diagnosis, quality of life, and associated psychosocial information received

Eligibility Criteria

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	18 Years to 45 Years (Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

DISEASE CHARACTERISTICS:

• Diagnosis of breast cancer, germ cell tumor, colon cancer, leukemia, lymphoma, or sarcoma

  • Free of disease
• Completed treatment within the past 1-2 years

PATIENT CHARACTERISTICS:

• ECOG performance status 0-1
• Must be able to read and self-complete study questionnaires
• No psychological conditions that may prevent participation in the study

PRIOR CONCURRENT THERAPY:

• See Disease Characteristics
• No concurrent treatment (hormonal treatment for breast cancer is allowed)

Contacts and Locations

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Locations

Spain
Institut Catala D'Oncologia	Recruiting
l'Hospitalet de Llobregat, Spain, 08907
Contact: Josefina Rivera, RGN, MSN 34-93-260-7332 jrivera@iconcologia.net

Sponsors and Collaborators

Institut Català d'Oncologia

Investigators

Principal Investigator:	Josefina Rivera, RGN, MSN	Institut Català d'Oncologia

More Information

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

ClinicalTrials.gov Identifier:	NCT01295463 History of Changes
Other Study ID Numbers:	ICO-FERTI; CDR0000695000 ( Registry Identifier: PDQ (Physician Data Query) ); EU-21105
First Posted:	February 14, 2011
Last Update Posted:	August 12, 2013
Last Verified:	February 2011

Keywords provided by National Cancer Institute (NCI):

sexual dysfunction; psychosocial effects of cancer and its treatment; infertility; colon cancer; male breast cancer; breast cancer; germ cell tumor; ovarian sarcoma; uterine sarcoma; chronic lymphocytic leukemia; osteosarcoma; chronic myelogenous leukemia; non-Hodgkin lymphoma; adult acute myeloid leukemia with 11q23 (MLL) abnormalities; adult acute myeloid leukemia with inv(16)(p13;q22)

adult acute myeloid leukemia with t(15;17)(q22;q12); adult acute myeloid leukemia with t(16;16)(p13;q22); adult acute myeloid leukemia with t(8;21)(q22;q22); mast cell leukemia; hairy cell leukemia; prolymphocytic leukemia; adult acute lymphoblastic leukemia; adult acute myeloid leukemia; adult Hodgkin lymphoma; adult T-cell leukemia/lymphoma; small intestine lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; mycosis fungoides/Sezary syndrome; intraocular lymphoma

Additional relevant MeSH terms:

Infertility; Genital Diseases, Male; Genital Diseases, Female